Price T Rowe Associates Inc Alkermes Plc. Call Options Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
407Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$787 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$492 Million0.01% of portfolio
-
State Street Corp Boston, MA8.02MShares$217 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$186 Million3.72% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny5.74MShares$155 Million0.3% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.44B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...